Explore India's oil and gas strategy amid rising global energy prices and U.S.-Iran tensions, highlighting challenges and ...

Compounding pharmacies are illegally selling GLP-1 drugs, and the FDA is determined to shut that pathway down.

Atlassian (NASDAQ:TEAM) has had a punishing stretch. Shares are down 53.47% year to date. Over the past year the stock has fallen 150%, a sharp retreat from a 52-week high of $242. Most analysts hold ...

Testing identified significant impurity formation when tirzepatide is compounded with B12 variants, suggesting chemical incompatibility that is not evaluated under FDA review pathways. Uncertainty ...

Medical groups affiliated with telehealth companies the FDA warned about marketing of compounded weight loss drugs may be under the microscope, too ...

Q4 2025 Earnings Call March 12, 2026 1:00 PM EDTCompany ParticipantsCraig Armitage - Investor Relations OfficerDavid Feller ...

ScaleX Digital transforms marketing from a short-term expense into a compounding digital asset through data-driven infrastructure and financial modeling ...

Hims & Hers Health (NYSE:HIMS) looked like a fallen growth star earlier this year. The telehealth platform was hammered by the FDA’s aggressive crackdown on compounded GLP-1 drugs, complete with ...

This data really does show that buying a home can be an accelerator for your net worth,” explains Hannah Jones, Realtor.com senior economic research analyst.

She found plenty of options and settled on a cheaper, imitation version of the name-brand drugs for $177 a month that she could buy without going through insurance. “It’s absolutely odd,” she said of ...

ONAR Holding Corporation (OTCQB: ONAR) ("ONAR" or the "Company"), the Operating System for Modern Marketing, today announced that it has successfully completed ...

Lilly is warning the public that tirzepatide mixed with B12 is creating an impurity with “unknown effects” in humans.